How AI is uniting regulatory strategy and biomanufacturing.AI is no longer a futuristic add-on in the life sciences. It is rapidly becoming infrastructure.
Forget the drug discovery hype. Here’s how the world’s largest pharma company is seeing a payoff from AI right now.
Active pharmaceutical ingredients (APIs) form the backbone of modern medicine, driving the efficacy and safety of countless therapeutic products. According to a recent report by MarketsandMarkets, the ...
After tariffs rose to the highest levels in centuries, the U.S. lost tens of thousands of manufacturing jobs last year. In December, WSJ’s Gavin Bade went inside Detroit to learn why—and meet the ...
Flow Traders has integrated a new exchange API key management system into its crypto trading infrastructure, responding to growing concern over operational risks tied to automated trading. The ...
Agno Pharma Acquires Actylis’s CDMO Manufacturing Asset, the Legacy Cascade Chemistry Business based in Eugene, Oregon, Strengthening Agno’s US cGMP API Development and Manufacturing Capabilities Agno ...
Oil industry executives have voiced that reviving Venezuela's oil production will be a long and costly process. Companies will need stable, legally defined frameworks, security for investments, and ...
A monthly overview of things you need to know as an architect or aspiring architect. Unlock the full InfoQ experience by logging in! Stay updated with your favorite authors and topics, engage with ...
The MarketWatch News Department was not involved in the creation of this content. Flow to Operate as Brand-Led Business; Cizzle Brands Corporation Acquires Manufacturing Operations; Rucker Investments ...
Inke is a manufacturer of inhalation active pharmaceutical ingredients Inke is based in Barcelona, Spain Pharmanoid’s products are authorized for commercialization in more than 25 countries Inke, ...
A controversy is swirling at a Texas university. The trigger? A flowchart. On Dec. 1, the new chancellor of the Texas Tech University system sent professors a diagram laying out a chain of approval ...